Chaïbi, Khalil https://orcid.org/0000-0001-9106-586X
Akrour, Yanis
Louis, Guillaume
Lefevre, Laurent Martin
Pons, Bertrand
Moschietto, Sébastien
Boulet, Eric
Hajage, David
Lebbah, Saïd
Quenot, Jean-Pierre
Sangla, Frederic
Dreyfuss, Didier
Gaudry, Stéphane
Legouis, David
,
Gaudry, Stéphane
Hajage, David
Schortgen, Frédérique
Martin-Lefevre, Laurent
Pons, Bertrand
Boulet, Eric
Boyer, Alexandre
Chevrel, Guillaume
Lerolle, Nicolas
Carpentier, Dorothée
de Prost, Nicolas
Lautrette, Alexandre
Bretagnol, Anne
Mayaux, Julien
Nseir, Saad
Mégarbane, Bruno
Thirion, Marina
Forel, Jean-Marie
Maizel, Julien
Yonis, Hodane
Markowicz, Philippe
Thiery, Guillaume
Tubach, Florence
Ricard, Jean-Damien
Dreyfuss, Didier
Lebbah, Saïd
Louis, Guillaume
Moschietto, Sébastien
Titeca-Beauport, Dimitri
La Combe, Béatrice
Besset, Sébastien
Combes, Alain
Robine, Adrien
Beuzelin, Marion
Badie, Julio
Bohé, Julien
Coupez, Elisabeth
Chudeau, Nicolas
Barbar, Saber
Vinsonneau, Christophe
Thevenin, Didier
Lakhal, Karim
Aissaoui, Nadia
Grange, Steven
Leone, Marc
Lacave, Guillaume
Poirson, Florent
Asehnoune, Karim
Geri, Guillaume
Klouche, Kada
Argaud, Laurent
Rozec, Bertrand
Cadoz, Cyril
Andreu, Pascal
Reignier, Jean
Quenot, Jean-Pierre
Forel, Jean-Marie
Thiery, Guillaume
Article History
Received: 28 November 2025
Accepted: 20 February 2026
First Online: 17 March 2026
Declarations
:
: The authors declare no competing interests.
: The AKIKI trial was approved by the Comité de Protection des Personnes Île-de-France VI; AKIKI2 was approved by the Comité de Protection des Personnes Sud-Est V for all participating French centers. The DOORS analysis used de-identified data from these trials. The external-validation cohort obtained approval from the local ethics committee in Geneva, with waiver of informed consent owing to the retrospective analysis of de-identified data, in accordance with local regulations.